Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis.

Büning, C; Schmidt, H H-J; Molnar, T; De Jong, D J; Fiedler, T; Bühner, S; Sturm, A; Baumgart, D C; Nagy, F; Lonovics, J; Drenth, J P H; Landt, O; Nickel, R; Büttner, J; Lochs, H; Witt, H

Büning, C; Schmidt, H H-J; Molnar, T; De Jong, D J; Fiedler, T; Bühner, S; Sturm, A; Baumgart, D C; Nagy, F; Lonovics, J; Drenth, J P H; Landt, O; Nickel, R; Büttner, J; Lochs, H; Witt, H.

Affiliation

Büning C; Department of Gastroenterology, Hepatology and Endocrinology, Charité, Campus Mitte, Universitätsmedizin Berlin, Berlin, Germany. carsten.buening@charite.de

Aliment Pharmacol Ther ; 26(7): 1025-33, 2007 Oct 01.

Article de En | MEDLINE | ID: mdl-17877509

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Rectocolite hémorragique / Maladie de Crohn / Récepteurs aux interleukines / Tumeurs du côlon / Polymorphisme de nucléotide simple / Protéine adaptatrice de signalisation NOD2 Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limites: Adult / Female / Humans / Male Langue: En Journal: Aliment Pharmacol Ther Sujet du journal: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Année: 2007 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Royaume-Uni

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links